Moderna teams up with Novocol for fill-finish, packaging of mRNA vaccines in Canada

By NS Healthcare Staff Writer

05 May 23

Under the terms of the agreement, Novocol Pharma will provide fill-finish and packaging for vaccines manufactured at Moderna’s…

PharmaceuticalsContract Manufacturing

Volastra in-licenses Amgen’s sovilnesib; secures $60m funding

By NS Healthcare Staff Writer

08 Mar 23

The financing, led by founding investors Polaris Partners and ARCH Venture Partners alongside Lilly, will support Volastra’s portfolio…

PharmaceuticalsPartnerships and Licensing Agreements

FDB agrees to manufacture Argenx’s antibody therapy efgartigimod

By NS Healthcare Staff Writer

28 Oct 22

Under the agreement, FDB will provide drug substance manufacturing of efgartigimod at its large-scale biomanufacturing facility in Hillerød,…

PharmaceuticalsContract Manufacturing

AstraZeneca, Gatehouse Bio extend partnership to develop RNA therapeutics for heart failure

By NS Healthcare Staff Writer

09 Sep 22

The collaboration will combine AstraZeneca’s expertise in RNA therapeutics with Gatehouse Bio’s capabilities in small RNA compounds to…

PharmaceuticalsPartnerships and Licensing Agreements

Moderna to supply additional doses of bivalent Covid-19 booster vaccine to US

By NS Healthcare Staff Writer

01 Aug 22

Under the new agreement with the US government, the biotechnology company will receive up to $1.74bn for 66…

PharmaceuticalsPartnerships and Licensing Agreements

GenScript, ACT Therapeutics partner to develop new CAR-T Cell therapies

By NS Healthcare Staff Writer

13 Jul 22

GenScript ProBio will support ACT therapeutics’ CAR-T Platform (ACT platform), an immune cell-based cell and gene therapy technology…

PharmaceuticalsPartnerships and Licensing Agreements

Roche licenses Ionis’ investigational therapy for rare kidney disease

By NS Healthcare Staff Writer

12 Jul 22

Ionis will receive $55m from Roche, in exchange for licensing IONIS-FB-LRx and achieving a development milestone in the…

PharmaceuticalsPartnerships and Licensing Agreements

Akebia terminates license deal with Otsuka to retain vadadustat rights

By NS Healthcare Staff Writer

04 Jul 22

The company is entitled to receive a settlement fee of $55m and will assume responsibility for the marketing…

PharmaceuticalsPartnerships and Licensing Agreements

ViiV Healthcare teams up with MPP to license patents related to HIV drug cabotegravir

By NS Healthcare Staff Writer

30 May 22

ViiV Healthcare and MPP are actively negotiating on terms of a voluntary licensing agreement, which would help widen…

PharmaceuticalsPartnerships and Licensing Agreements

Exscientia, Oxford TDI partner for Xcellomics drug discovery programme

By NS Healthcare Staff Writer

11 Mar 22

Xcellomics programme was created by the two Oxford-based institutions to advance the early-stage drug discovery research by academic…

PharmaceuticalsDrug discovery